OptMed, Inc. (OMED)

OptMed will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -3.86M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OMED

OptMed is a clinical-stage medical device company focused on the development and commercialization of novel surgical adhesives for the localized treatment of patients with external and internal wounds. Our proprietary technology platform is based on a chemistry called methylidene malonate (“MM212”), a biocompatible polymer originally designed for drug delivery which has been extensively tested for biocompatibility and adhesive properties in topical and internal applications. MM212-based surgical adhesives have unique versatile properties wh... [Read more...]

Industry Health Care
Founded 2007
CEO Ervin Braun
Employees 4
Stock Exchange NASDAQ
Ticker Symbol OMED
Full Company Profile

Financial Performance

Financial Statements


Surgical adhesive developer OptMed files for a $23 million IPO

OptMed, which is commercializing topical tissue adhesives used in surgery, filed on Wednesday with the SEC to raise up to $23 million in an initial public offering.

OptMed IPO Registration Document (S-1)

OptMed} has filed to go public with an IPO on the NASDAQ.